Cargando…

When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study

AIMS: The aim of this analysis was to assess the efficacy and safety of intensifying insulin therapy from a basal-only regimen to biphasic insulin aspart 30 (BIAsp 30) in patients with type 2 diabetes previously failing to reach glycaemic targets. METHODS AND PATIENTS: The analysis is based on data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, H C, Guler, S, Shestakova, M
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Endocrinology & Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438599/ https://www.ncbi.nlm.nih.gov/pubmed/18479365 http://dx.doi.org/10.1111/j.1742-1241.2008.01792.x

Ejemplares similares

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™ observational study
por: Gumprecht, J, et al.
Publicado: (2009)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study
por: Jude, Edward B., et al.
Publicado: (2021)

PSUN227 A retrospective comparison of Basal Bolus using Glargine U-300 and Glulisine with Premix Insulin
por: Abraham, Santhosh, et al.
Publicado: (2022)

Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
por: Shi, Li Xin, et al.
Publicado: (2017)

Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations
por: Orozco‐Beltran, D., et al.
Publicado: (2016)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting
por: Altemimi, Mahmood Thamer, et al.
Publicado: (2020)

PSUN181 Diabetes-related outcomes following use of basal-bolus insulin vs. premixed insulin in a VA population with Type 2 diabetes: A retrospective chart review.
por: Izuora, Kenneth, et al.
Publicado: (2022)

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
por: Moon, Shinje, et al.
Publicado: (2021)

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
por: Bellido, Virginia, et al.
Publicado: (2015)

Basal-bolus or premixed? Shedding light on optimal insulin regime for type 1 diabetes
por: Louise Walton, Emma
Publicado: (2018)

Initiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix Regimens
por: Downie, Michelle, et al.
Publicado: (2016)

SAT108 What A Simple Switch Can Achieve; A Case Of Severe Insulin-induced Lipohypertrophy
por: Ayub, Tooba, et al.
Publicado: (2023)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Can technology help achieve sustainable intensification? Evidence from milk recording on Irish dairy farms
por: Balaine, Lorraine, et al.
Publicado: (2020)

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review
por: Meece, Jerry
Publicado: (2018)

Inpatient Glycaemic Control is Poor in Patients Receiving Insulin Therapy
por: Reidy, Niall, et al.
Publicado: (2021)

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice*
por: Hammer, H, et al.
Publicado: (2007)

Acute Administration of Unacylated Ghrelin Has No Effect on Basal or Stimulated Insulin Secretion in Healthy Humans
por: Tong, Jenny, et al.
Publicado: (2014)

Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus
por: Raccah, D., et al.
Publicado: (2017)

Clinical study of treatment switching from premixed insulin to basal insulin combined with oral hypoglycemic drugs in patients with type 2 diabetes
por: Zhang, Ying, et al.
Publicado: (2014)

The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapy
por: Liu, Jhih-Syuan, et al.
Publicado: (2023)

A Review of the Impact of Smoking on Inhaled Insulin: Would You Stop Smoking if Insulin Can Be Inhaled?
por: Malhotra, Parul, et al.
Publicado: (2020)

Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
por: Moore, Mary Courtney, et al.
Publicado: (2014)

Low basal metabolic rate as a risk factor for development of insulin resistance and type 2 diabetes
por: Maciak, Sebastian, et al.
Publicado: (2020)

Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes
por: Mehta, Roopa, et al.
Publicado: (2022)

Insulin Augmentation of Glucose-Stimulated Insulin Secretion Is Impaired in Insulin-Resistant Humans
por: Halperin, Florencia, et al.
Publicado: (2012)

Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
por: Vaag, Allan, et al.
Publicado: (2012)

Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia
por: Beljić Živković, Teodora M., et al.
Publicado: (2018)

Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes
por: Mocarski, Michelle, et al.
Publicado: (2018)

Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry
por: Danne, Thomas, et al.
Publicado: (2015)

Insulin Resistance and Hyperinsulinemia: You can't have one without the other
por: Kim, Sun H., et al.
Publicado: (2008)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
por: Liu, Guangxu, et al.
Publicado: (2018)

Modern basal insulin analogs: An incomplete story
por: Singh, Awadhesh Kumar, et al.
Publicado: (2014)

High-Protein, Low-Glycaemic Meal Replacement Decreases Fasting Insulin and Inflammation Markers—A 12-Month Subanalysis of the ACOORH Trial
por: Kempf, Kerstin, et al.
Publicado: (2021)

Impact of Pocket Insulin Dosing Guide on Utilization of Basal/Bolus Insulin by Internal Medicine Resident Physicians
por: Mamillapalli, Chaitanya K, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals
por: Lamos, Elizabeth Mary, et al.
Publicado: (2015)

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis
por: Sharplin, Peter, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_j46og2cmpjm6q6q2ocvc8ms15q